Federal appeals court rejects NIH research funding cuts
Source: SeekingAlpha
2026-01-06 07:16:59 ET
More on Thermo Fisher Scientific, Danaher, etc.
- Thermo Fisher: Refinding Some Momentum
- Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
- Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Thermo Fisher upgraded at Citi on boost in pharma spending
- Waters raised to Outperform at Wolfe on BD Life Sciences deal
Read the full article on Seeking Alpha
For further details see:
Federal appeals court rejects NIH research funding cuts
Tecan Ag Hombrchtkn
NASDAQ: TCHBF
TCHBF Trading
0.0% G/L:
$160 Last:
100 Volume:
$160 Open:
TCHBF Latest News
April 25, 2025 10:44:00 am
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
January 27, 2025 01:35:00 pm
Tecan Introduces Veya: Bringing Digital, Scalable Automation to Labs Worldwide
